Bioxodes’ antithrombotic meets development milestones – Company to launch Series A investment round to bring the product to the clinic
19 September 2014 | By Andrew Lloyd & Associates
Bioxodes SA announces that it has successfully brought its lead product, Ir-CPI, through pre-clinical development confirming its potential as the first in a new class of antithrombotic medicines...